# Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

> **NCT00232583** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 58 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** Insulin
- **DRUG:** Metfomin
- **DRUG:** Pioglitazone
- **DRUG:** glyburide

## Key facts

- **NCT ID:** NCT00232583
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232583, "Preservation of Beta-cell Function in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00232583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*